NFCR-Backed Technology Receives FDA’s Assent for Lymphoma Clinical Trials
FOR IMMEDIATE RELEASE: March 12, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 ROCKVILLE, MD – A drug and drug delivery candidate technology, research into which has been funded by the National Foundation for Cancer Research (NFCR), has…...
A Rapidly Emerging Field of Cancer Treatment
The human body normally runs like a well-oiled machine. It is able to activate muscles and run repairs without a conscious thought. One of the truly fascinating components of the human body is the immune system. The immune system is able to identify potentially harmful foreign matter and destroy it.…...
Immunotherapy: Where We’re Headed
It is the “new territory” of oncology: Getting the immune system to successfully fight a standing cancer. No other biological system within our bodies is more suited, adept or evolved to such a purpose. Indeed, our immune system is remarkably successful in spotting and destroying the tiny genetic mutations from…...
Strategic Media Partner
